Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2014: Volume 19/ Issue 16 Article 7
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 19, Issue 16, 24 April 2014
News
The European Medicines Agency publishes interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the European Union
  1. European Centre for Disease Prevention and Control (ECDC) Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. The European Medicines Agency publishes interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the European Union. Euro Surveill. 2014;19(16):pii=20778. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20778

On 15 April, the European Medicines Agency (EMA) published an interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the European Union. The interim guidance focuses on enhanced safety surveillance and outlines principles to be followed for improved continuous routine surveillance for influenza vaccines [1].
More details can be found here.


References
  1. European Medicines Agency (EMA). Interim guidance on enhanced safety surveillance for
    seasonal influenza vaccines in the EU. London: EMA; 2014. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/04/WC500165492.pdf


Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.